Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02HRD
|
|||
| Former ID |
DIB002213
|
|||
| Drug Name |
KLS-0611
|
|||
| Synonyms |
Mucin stimulator (dry eye), Kissei
Click to Show/Hide
|
|||
| Indication | Xerophthalmia [ICD-11: 5B55.Y] | Phase 2 | [1] | |
| Company |
Kissei Pharmaceutical Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mucin (MUC) | Target Info | Stimulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00721656) Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes. U.S. National Institutes of Health. | |||
| REF 2 | WO patent application no. 2011,1034,23, Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.